XML 37 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Note 3 - Balance Sheet Details - Summary of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Notes To Financial Statements [Abstract]    
Accrued accounts payable $ 118 $ 146
Accrued clinical trial expenses 174 20
Accrued CMC expenses 264 5
Accrued director stipends 59 106
Accrued severance and benefits 0 131
Accrued joint development expenses 669 98
Current portion of contingent consideration obligation 0 143
Accrued other 225 182
Accrued liabilities, current, Total $ 1,509 $ 831